HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Lorenzo Gonzalez-Lavin Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonzalez-Lavin, L. Articles by Daughters, G. Search for Related Content PubMed PubMed Citation Articles by Gonzalez-Lavin, L. Articles by Daughters, G.

Ann Thorac Surg 1983;36:270-280
© 1983 The Society of Thoracic Surgeons

---

Articles

Five-Year Experience with the Ionescu-Shiley Bovine Pericardial Valve in the Aortic Position

From the Departments of Cardiovascular Surgery, The Ingham Medical Center, Lansing, MI, and the Palo Alto Medical Clinic, Health Care Division of the Palo Alto Medical Foundation, Palo Alto, CA

^* Address reprint requests to Dr. Gonzalez-Lavin, Palo Alto Medical Clinic, 300 Homer Ave, Palo Alto, CA 94301

Between February, 1977, and April, 1982, 168 patients underwent aortic valve replacement (AVR) with an Ionescu-Shiley bovine pericardial valve. Concomitant procedures were performed in 71 patients. There were 12 hospital deaths (7.1%). Among patients having AVR only, there were 5 deaths (5.2%). Assessment included valve durability, incidence of thromboembolism, clinical improvement, and patient survival. There was 100% follow-up.

Actuarial freedom from intrinsic valve failure at 5 years was 96.3 ± 3.6%. Intrinsic valve failure occurred only once, 0.3 episodes per 100 patient-years. Four patients had thromboembolic complications. As for clinical status, 99.3% of surviving patients are in New York Heart Association Functional Class I or II, including 79 patients with valve sizes 17,19, or 21 mm (56%). Among 13 late deaths, 9 were related to the cardiovascular system. Overall patient survival is 84.9 ± 4.7%. Among the 92 patients with isolated AVR, 87.8 ± 5.9% are alive at the 5-year follow-up. If the incidence of valve failure is not altered in years to come, the durability of the Ionescu-Shiley bovine pericardial valve will surpass that of previous bioprostheses.

This article has been cited by other articles:

				D. M. Cosgrove, B. W. Lytle, P. C. Taylor, M. T. Camacho, R. W. Stewart, P. M. McCarthy, D. P. Miller, M. R. Piedmonte, and F. D. Loop The Carpentier-Edwards pericardial aortic valve: Ten-year results J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 651 - 662. [Abstract] [Full Text]

				W. Daenen, L. Noyez, E. Lesaffre, Y. Goffin, and G. Stalpaert The Ionescu-Shiley Pericardial Valve: Results in 473 Patients Ann. Thorac. Surg., November 1, 1988; 46(5): 536 - 541. [Abstract] [PDF]

				L. H. Edmunds Jr. Thrombotic and Bleeding Complications of Prosthetic Heart Valves Ann. Thorac. Surg., October 1, 1987; 44(4): 430 - 445. [Abstract] [PDF]

				M. P. Brais, J. P. Bedard, W. Goldstein, A. Koshal, and W. J. Keon Ionescu-Shiley Pericardial Xenografts: Follow-up of Up to 6 Years Ann. Thorac. Surg., February 1, 1985; 39(2): 105 - 111. [Abstract] [PDF]